Viewing Study NCT05900895


Ignite Creation Date: 2025-12-24 @ 2:16 PM
Ignite Modification Date: 2026-01-31 @ 1:42 PM
Study NCT ID: NCT05900895
Status: RECRUITING
Last Update Posted: 2025-11-20
First Post: 2023-05-24
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Estradiol Plus Olaparib for Breast Cancer (PHOEBE)
Sponsor: Mary D Chamberlin
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: STUDY02002007
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View